Gyeonggi-do, South Korea

Hyuk Woo Lee

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Hk Inno.n Corporation, Cj Healthcare Corporation, Ewha University-Industry Collaboration Foundation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyuk Woo Lee. Retrieved from https://idiyas.com/inventor/hyuk-woo-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2014 - 2023)
  • Hwaseong-si, KR (2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Innovator Profile: Hyuk Woo Lee from Gyeonggi-do, KR**

Introduction

Hyuk Woo Lee is a prominent inventor based in Gyeonggi-do, South Korea. With an impressive portfolio of five patents, his contributions to the field of chemical innovation have garnered attention in various industries, particularly in pharmaceuticals.

Latest Patents

Hyuk Woo Lee's recent patents demonstrate his expertise and focus on the development of novel compounds. One of his latest innovations is titled "Intermediates for optically active piperidine derivatives and preparation methods thereof." This invention outlines a preparation method that allows for the industrial production of highly pure optically active tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate. The method utilizes commercially available reagents and solvents, enabling the production of this compound in high yield.

Another significant patent authored by Lee is a "Heterocyclic compound as a protein kinase inhibitor." This invention introduces a novel compound with protein kinase inhibition activity. The compound—including its stereoisomers and pharmaceutically acceptable salts—holds promise in the prevention and treatment of diseases related to protein kinases, such as cancer, autoimmune diseases, neurological disorders, and metabolic conditions.

Career Highlights

Hyuk Woo Lee has contributed his expertise to notable companies, including Hk Inno.n Corporation and CJ Healthcare Corporation. His work in these organizations has positioned him at the forefront of pharmaceutical research and development, particularly focusing on innovative drug formulations.

Collaborations

Throughout his career, Hyuk Woo Lee has collaborated with talented individuals such as Eun Sun Kim and Jae Hong Kweon. These partnerships have facilitated the exchange of ideas and spurred the development of groundbreaking inventions in the pharmaceutical sector.

Conclusion

As an inventor with a strong foundation in chemical innovations, Hyuk Woo Lee continues to make significant strides in the field. His latest patents not only reflect his commitment to advancing pharmaceutical research but also underscore the potential for innovative solutions to address critical health challenges. With his expertise and collaborative spirit, Lee’s contributions to science and technology remain influential.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…